Benztropine (mesylate)

Benztropine (mesylate)

CAT N°: 16214
Price:

From 37.00 31.45

Benztropine is an antagonist of M1 muscarinic acetylcholine receptors (Ki = 0.59 nM in rat brain membranes).{26585} It is selective for M1 receptors over the serotonin transporter (Ki = 5,150 nM), however, it also binds to the dopamine transporter and inhibits dopamine reuptake (Kis = 237 and 130 nM, respectively).{26585,20213,26584} Benztropine also inhibits acid sphingomyelinase by 87% when used at a concentration of 10 mM.{26583} Formulations containing benztropine have been used in the management of Parkinson’s disease symptoms such as involuntary tremor and dystonia.

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • (3-endo)-3-(diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane, monomethanesulfonate
  • Correlated keywords
    • anticholinergic antimuscarinic antagonizes dopamine transporter inhibition sphingomyelinase synthetics atropines diphenhydramines mesylates involuntary tremors dystonias uptake benztropinum cobrentin akitan apo pms cogentinol benzatropinum methanesulfonate MK02 MK-02 NSC169913 tropines benzohydryl ether 3-diphenylmethoxytropane benzotropine benzatropine anti-cholinergic muscarinic Cogentin
  • Product Overview:
    Benztropine is an antagonist of M1 muscarinic acetylcholine receptors (Ki = 0.59 nM in rat brain membranes).{26585} It is selective for M1 receptors over the serotonin transporter (Ki = 5,150 nM), however, it also binds to the dopamine transporter and inhibits dopamine reuptake (Kis = 237 and 130 nM, respectively).{26585,20213,26584} Benztropine also inhibits acid sphingomyelinase by 87% when used at a concentration of 10 mM.{26583} Formulations containing benztropine have been used in the management of Parkinson’s disease symptoms such as involuntary tremor and dystonia.

We also advise you